Skip to main content

Table 1 Demographic characteristics of N = 23 LGBTQ+ participants

From: Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs

 

Range

Mean (SD)

Age in years

21-38

27.5 (5.1)

 

n

%

Education

 Primary school/some high school

2

8.7

 High school diploma/GED

7

30.4

 Some college, no degree

3

13.0

 Associate degree

2

8.7

 Bachelor’s degree

8

34.8

 PhD, MD, or other doctoral degree

1

4.4

Race & Ethnicity

 Black/African-American, non-Hispanic

7

30.4

 Latinx, any race

4

17.4

 Multiracial, non-Hispanic

3

13.0

 White, non-Hispanic

9

39.1

Sexual orientation

 Bisexual

5

21.7

 Gay

4

17.4

 Lesbian

4

17.4

 Prefer not to specify

1

4.4

 Pansexual

2

8.7

 Queer

7

30.4

Gender identity

 Cisgender man

4

17.4

 Cisgender woman

8

34.8

 Non-binary (two of whom also identified as transgender)

4

17.4

 Transgender man

6

26.1

 Transgender woman

1

4.4

Substance use treatment and other related services experience

 Twelve-step programs (e.g., Alcoholics Anonymous, Narcotics Anonymous)

20

87.0

 Outpatient treatment

13

56.5

 Individual therapy for substance use (outside of a treatment program)

13

56.5

 Inpatient treatment

12

52.2

 Detox

11

47.8

 Medications for opioid use disorder (e.g., Suboxone, methadone)

8

34.8

 Syringe exchange services

5

21.7

 Sober living

2

8.7

 Office-based opioid treatment

1

4.3

 None – i.e., no experience with substance use treatment or other related services

2

8.7

Past 12-month substance use

 Poly-substance use

23

100.0

 Alcohol

22

95.65

 Opioidsa (e.g., prescription,b e.g., Oxycontin, Vicodin, Percocet], heroin, fentanyl)

21

91.30

 Cannabis

14

60.87

 Ecstasy

12

52.17

 Hallucinogens (e.g., LSD, mushrooms)

11

47.83

 Prescriptionb sedatives (e.g., Valium, Ativan, Xanax, Klonopin)

9

39.13

 Prescriptionb stimulants (e.g., Adderall, Ritalin)

8

34.78

 Poppers

6

26.09

 Injection drug use (any drug)

6

26.09

 Powered cocaine

5

21.74

 Crack cocaine

4

17.39

 Crystal methamphetamine

4

17.39

 Ketamine

4

17.39

 Other drugs (e.g., Gabapentin; K2 spice)

3

13.04

 GHB

1

4.35

Past 12-month substance use frequency

 Binge alcohol usec

22

 

  Daily/almost daily

10

45.45

  Weekly

7

31.82

  Monthly

0

0.00

  Less than monthly

5

22.73

 Opioid use

21

 

  Daily/almost daily

17

80.95

  Weekly

3

13.64

  Monthly

1

4.55

  Less than monthly

0

0.00

  1. NOTE LGBTQ+ Lesbian, gay, bisexual, transgender, queer, and other populations within the LGBTQ community (e.g., asexual individuals)
  2. aTwo participants were in opioid use recovery at the time of the interview but reported prior weekly opioid use
  3. bUsed other than as prescribed by a doctor, e.g., higher quantity or frequency than prescribed, someone else’s prescription
  4. cAssigned female at birth = 4 or more drinks in one sitting; assigned male at birth = 5 or more drinks in one sitting